Lifeline Drugs revised outcome of board meeting

With reference to the earlier announcement dated February 05, 2013 regarding Outcome of Board Meeting, Lifeline Drugs & Pharma Ltd has now informed BSE that that there was a typographical error in submission of Outcome of Board Meeting held on February 05 2013. The Correct Outcome of Board Meeting should be read as under:- The Board of Directors of the Company at its meeting held on February 05, 2013 have allotted 7,38,000 Equity Shares of Rs. 10/- each for cash at a premium of Rs. 50/- per share under Section 81(1A) of the Companies Act, 1956 pursuant to the authority given by the members in the EOGM held on January 18, 2013.Source : BSE

Read all announcements in Lifeline Drugs